HIS
LGND icon

Harvest Investment Services’s Ligand Pharmaceuticals LGND Stock Holding History

Harvest Investment Services’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-6,066
Closed -$368K – 169
2019
Q3 		$368K Sell
6,066
-2,088
-26% -$131K 0.18% 93
2019
Q2 		$584K Sell
8,154
-446
-5% -$32.9K 0.33% 69
2019
Q1 		$665K Buy
+8,600
New +$652K 0.39% 62

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Harvest Investment Services's LGND Position: Q4 2019 in Review

Harvest Investment Services sold out of Ligand Pharmaceuticals (LGND) in Q4 2019, closing a stake of 6,066 shares — an estimated $368K sold.

Harvest Investment Services first reported a position in LGND in Q1 2019 and held it in 3 quarters. The position peaked at $665K in Q1 2019. 266 funds tracked by Wall St. Rank hold LGND as of Q4 2019.

  • Harvest Investment Services reported no remaining Ligand Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Harvest Investment Services sold 6,066 Ligand Pharmaceuticals shares in Q4 2019, an estimated $368K.
  • Harvest Investment Services first reported a position in Ligand Pharmaceuticals in Q1 2019 and held it in 3 quarters.
  • Harvest Investment Services's Ligand Pharmaceuticals position peaked at $665K in Q1 2019.
  • 266 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2019.

Based on Harvest Investment Services's 13F filing for Q4 2019, filed 17 Jan 2020.